Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue	$ 559,370	$ 388,654	$ 1,870,306	$ 821,398
Cost of goods sold	955,466	326,671	2,030,447	645,463
Gross profit (loss)	(396,096)	61,983	(160,141)	175,935
Operating expenses:
Research and development	4,165,732	664,145	9,135,410	999,449
Sales and marketing	646,713	304,880	1,873,955	863,400
General and administrative	6,805,788	1,482,018	14,168,782	3,445,749
Total operating expenses	11,618,233	2,451,043	25,178,147	5,308,598
Loss from operations	(12,014,329)	(2,389,060)	(25,338,288)	(5,132,663)
Other income (expense):
Other income, net	12,254	17,503	40,943	17,523
Interest expense		(95,469)	(2,312)	(324,670)
Loss on extinguishment of debt		(213,700)		(566,925)
Other income (expense), net	12,254	(291,666)	38,631	(874,072)
Net loss	(12,002,075)	(2,680,726)	(25,299,657)	(6,006,735)
Deemed dividend on modification of Series H-5 warrants		(432,727)		(432,727)
Net loss Attributable to Common Stockholders	$ (12,002,075)	$ (3,113,453)	$ (25,299,657)	$ (6,439,462)
Net loss per share, basic and diluted	$ (0.33)	$ (0.13)	$ (0.73)	$ (0.54)
Basic and diluted weighted average Common Stock outstanding	36,312,478	23,599,967	34,615,858	11,896,906